Arrowhead Pharmaceuticals Inc. (ARWR) Misses Q3 EPS by 9c
Tweet
Share
E-mailGet Alerts ARWR Hot Sheet
Price: $66.89 -6.92%
Financial Fact:
NET INCOME (LOSS): -19.42M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Financial Fact:
NET INCOME (LOSS): -19.42M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) reported Q3 EPS of ($0.29), $0.09 worse than the analyst estimate of ($0.20). Revenue for the quarter came in at $45.89 million versus the consensus estimate of $37.52 million.
For earnings history and earnings-related data on Arrowhead Pharmaceuticals Inc. (ARWR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Paychex (PAYX) Tops Q1 EPS by 2c
- UBS Reiterates Buy Rating on KB Home (KBH) Amid Transition Back to Built-to-Order
- Citi expects Micron stock to rally into this event
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
